Not checked for notices yet.

A VHH-Based Anti-MUC1 Chimeric Antigen Receptor For Specific Retargeting Of Human Primary T Cells To MUC1-Positive Cancer Cells

Alireza Rajabzadeh, Fatemeh Rahbarizadeh, Davoud Ahmadvand and 2 more (opens in a new tab)

Cell Journal · 2021

doi:10.22074/cellj.2021.6917 (opens in a new tab)

Cited by papers we hold 2

Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment · 2023
No notice
A comprehensive comparison between camelid nanobodies and single chain variable fragments · 2021
No notice

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.